ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVCT Avacta

44.00
0.75 (1.73%)
Last Updated: 08:19:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 1.73% 44.00 43.00 45.00 44.00 43.25 43.25 317,337 08:19:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 23.25M -24.95M -0.0695 -6.33 155.29M
Avacta is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 43.25p. Over the last year, Avacta shares have traded in a share price range of 39.75p to 139.00p.

Avacta currently has 359,042,104 shares in issue. The market capitalisation of Avacta is £155.29 million. Avacta has a price to earnings ratio (PE ratio) of -6.33.

Avacta Share Discussion Threads

Showing 80451 to 80471 of 81050 messages
Chat Pages: Latest  3230  3229  3228  3227  3226  3225  3224  3223  3222  3221  3220  3219  Older
DateSubjectAuthorDiscuss
12/9/2024
18:05
Certainly one for the GRAND OLD DUKE OF YORK
waldron
12/9/2024
17:47
Technical analysis trend

Short Term Mid-Term Long Term

Resistance 77.00 82.50 154.00

Support 65.00 39.75 40.25

Certainly could do with more Analysts covering the company

waldron
12/9/2024
17:42
Investor Presentation via Investor Meet Company



Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted cancer treatments and powerful diagnostics, will announce its unaudited interim results on 30 September 2024 for the six months ended 30 June 2024.



Christina Coughlin, MD, PhD, Avacta's CEO, will discuss the results and the Company's operational and clinical progress via the Investor Meet Company platform on 30 September 2024 at 11:00 BST.



The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 29 September 2024, 09:00 BST, or at any time during the live presentation.



Investors can sign up to Investor Meet Company for free and add to meet AVACTA GROUP PLC via:





Investors who already follow Avacta on the Investor Meet Company platform will automatically be invited.



The Company will also post its results presentation on its website at the following page:

waldron
12/9/2024
16:21
Results could be interesting?

Short @ 74p.

dudishes
12/9/2024
16:03
The exact opposite.....CC wants to remain independent but Avacta can only do that by listing on Nasdaq.

No other reason to appoint Darlene Deptula-Hicks.

But the CEO is not alone and the twenty or so very senior people running Avacta and the Scientific Advisory Board all want a slice of the fame barreling their way.

vertizeasun
12/9/2024
15:47
But Chesh, why has Agent Smith disappeared in a puff of smoke. I think there are 2 possible reasons
a/ poor guy is ill
b/ something is wrong with the data,trials etc.
Sorry Chesh,I just can't get past this key point.
Aim smells.
You may call me a Fudster but I.m not fully convinced yet.
If they can deliver more modern warheads, the game will defo be on. The Doli delivery is clearly great, but a better warhead(s) may be necessary. I think they want to be taken over ...

amanitaangelicus
12/9/2024
12:58
Having held Avacta for several years, I've come to realise that there are two ways to track the progress of the company. First, the obvious one, the RNS's released by the company and the share price. The second, more subtle, is the change in the narrative of the FUDsters. Instead of continual, often contrived posts about AVA6k not working or feigned concern about the Heights CLN, we are now getting some along the lines of it may work but others including big pharma are already further along the track. Laughable. Keep trying guys. Holding my shares, you haven't persuaded me to sell.
cheshire pete
12/9/2024
11:35
JakNife,
BF not there yet why not ?
I suspect sabotage of Avacta share price as vested interests at play!
Happy to hold

fieldhouse
12/9/2024
11:35
JakNife,
BF not there yet why not ?
I suspect sabotage of Avacta share price as vested interests at play!
Happy to hold

fieldhouse
12/9/2024
10:08
fieldhouse1

"The potential for Avacta’s targeted warhead get’s more relevant by the day
It could be the saviour of the NHS"

Guess what you get if you type "targeted cancer warhead" into Google. You don't get pages for AVA 6000, that's for sure!

Try it and you'll have your eyes opened, you'll find:

* Numerous large pharma companies already have targeted cancer therapies, not just ones in Phase 1 trials but ones that have been approved by the FDA and are on sale now.

* The likes of AstraZeneca are spending $1.5bn to build a brand new factory in Singapore to manufacture their "next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody".



* Despite the wildest of wild claims by Avacta's shareholders actually Big Pharma already has tech that is miles better than Avacta's and hence they have absolutely no reason whatsoever to be interested in acquiring/partnering with Avacta.

JakNife

jaknife
12/9/2024
09:45
The NHS report is out today and highlights the unacceptable number of deaths from cancer !!
The potential for Avacta’s targeted warhead get’s more relevant by the day .
It could be the saviour of the NHS
Now there’s a thought !

fieldhouse
12/9/2024
08:47
Let's not forget about the pipeline of assets to be announced imminently as well. Plenty to look forward to here. Like I said, it's all looking rosy.
rajraj b
12/9/2024
08:05
Looks like Avacta have been fishing with a line and have now trawled a whole shoal !!
fieldhouse
12/9/2024
06:22
When was this recorded
carlsberg
12/9/2024
06:15
Well if I was sat on the sidelines I know what I would do
jacktrax
11/9/2024
20:58
24,000 views today. Certainly showing some interest.
rajraj b
11/9/2024
14:18
Very good science .
On generation 3 of av6000
Not just a general hit at the tumour, but targeted and guided like a precision guided missile .
The team have been busy

fieldhouse
11/9/2024
12:43
AI ...gene therapy ...simples.
amanitaangelicus
11/9/2024
07:30
Many thanks for the link Cheshire Pete. Very informative indeed.
bbd2
11/9/2024
05:48
Still no word from TimeLord Smith. Just what did he do? Gone- without a word. Sold his shares? Delays galore.
amanitaangelicus
11/9/2024
05:43
Yes seen it, we shall see if things really hot up before end next month won't hold me breath seen this spin so many times
repins1
Chat Pages: Latest  3230  3229  3228  3227  3226  3225  3224  3223  3222  3221  3220  3219  Older

Your Recent History

Delayed Upgrade Clock